Compile Data Set for Download or QSAR
maximum 50k data
Found 73 with Last Name = 'lallemand' and Initial = 'bi'
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22541(Clobenpropit | N''-[(4-chlorophenyl)methyl]{[3-(1H...)
Affinity DataKi:  0.339nM ΔG°:  -54.1kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22542(4-(1H-imidazol-4-ylmethyl)piperidine | 4-(1H-imida...)
Affinity DataKi:  0.407nM ΔG°:  -53.6kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22548(2-[3-(1H-imidazol-4-ylmethyl)phenyl]-4,4,6-trimeth...)
Affinity DataKi:  1nM ΔG°:  -51.4kJ/mole EC50:  2nMpH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22538(4-Benzyl-1H-imidazole derivative, 19 | 4-{[3-(2-ph...)
Affinity DataKi:  2nM ΔG°:  -49.7kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22540(4-Benzyl-1H-imidazole derivative, 21 | 4-{[3-(pent...)
Affinity DataKi:  3nM ΔG°:  -48.6kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22537(4-Benzyl-1H-imidazole derivative, 18 | 4-{[3-(3,3-...)
Affinity DataKi:  4nM ΔG°:  -47.9kJ/mole EC50:  8nMpH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22529(2-[3-(1H-imidazol-4-ylmethyl)phenyl]-4,4-dimethyl-...)
Affinity DataKi:  4nM ΔG°:  -47.9kJ/mole EC50:  16nMpH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H4 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22537(4-Benzyl-1H-imidazole derivative, 18 | 4-{[3-(3,3-...)
Affinity DataKi:  6nM ΔG°:  -46.9kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH4R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H4 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22536(1-[3-(1H-imidazol-4-ylmethyl)phenyl]-3,3-dimethylb...)
Affinity DataKi:  6nM ΔG°:  -46.9kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH4R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistamine H4 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22548(2-[3-(1H-imidazol-4-ylmethyl)phenyl]-4,4,6-trimeth...)
Affinity DataKi:  8nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH4R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22536(1-[3-(1H-imidazol-4-ylmethyl)phenyl]-3,3-dimethylb...)
Affinity DataKi:  32nM ΔG°:  -42.8kJ/mole EC50:  79nMpH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22533(4-Benzyl-1H-imidazole derivative, 14 | 4-[(3-pheny...)
Affinity DataKi:  33nM ΔG°:  -42.7kJ/mole EC50:  200nMpH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22549(2-[3-(1H-imidazol-4-ylmethyl)phenyl]-3-oxa-1-azasp...)
Affinity DataKi:  40nM ΔG°:  -42.2kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22534(2-[3-(1H-imidazol-4-ylmethyl)phenyl]pyridine | 4-B...)
Affinity DataKi:  41nM ΔG°:  -42.2kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22550(2-[3-(1H-imidazol-4-ylmethyl)phenyl]-1-oxa-3-azasp...)
Affinity DataKi:  56nM ΔG°:  -41.4kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22552((4R)-4-benzyl-2-[3-(1H-imidazol-4-ylmethyl)phenyl]...)
Affinity DataKi:  89nM ΔG°:  -40.2kJ/mole EC50:  79nMpH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22531(3-(1H-imidazol-4-ylmethyl)benzonitrile | 4-Benzyl-...)
Affinity DataKi:  155nM ΔG°:  -38.9kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22532(4-Benzyl-1H-imidazole derivative, 13 | 4-benzyl-1H...)
Affinity DataKi:  162nM ΔG°:  -38.8kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22547(4-(1H-imidazol-4-ylmethyl)aniline | 4-Benzyl-1H-im...)
Affinity DataKi:  257nM ΔG°:  -37.6kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22545(4-Benzyl-1H-imidazole derivative, 23 | 4-[(4-bromo...)
Affinity DataKi:  417nM ΔG°:  -36.4kJ/mole EC50:  631nMpH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22535(4-Benzyl-1H-imidazole derivative, 16 | 4-[3-(1H-im...)
Affinity DataKi:  427nM ΔG°:  -36.4kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22546(4-Benzyl-1H-imidazole derivative, 24 | 4-{[4-(3,3-...)
Affinity DataKi:  537nM ΔG°:  -35.8kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22551(4-(cyclohexylmethyl)-2-[3-(1H-imidazol-4-ylmethyl)...)
Affinity DataKi:  708nM ΔG°:  -35.1kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22544(4-(1H-imidazol-4-ylmethyl)benzonitrile | 4-Benzyl-...)
Affinity DataKi:  813nM ΔG°:  -34.8kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22539(4-({3-[2-(naphthalen-1-yl)ethynyl]phenyl}methyl)-1...)
Affinity DataKi:  1.74E+3nM ΔG°:  -32.9kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22553(2-[3-(1H-imidazol-4-ylmethyl)phenyl]-5,5-dimethyl-...)
Affinity DataKi:  2.51E+3nM ΔG°:  -32.0kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistamine H3 receptor(Homo sapiens (Human))
Vu University Amsterdam

LigandPNGBDBM22543(2-[4-(1H-imidazol-4-ylmethyl)phenyl]-4,4-dimethyl-...)
Affinity DataKi:  2.51E+3nM ΔG°:  -32.0kJ/molepH: 7.4 T: 2°CAssay Description:Ligand displacement assays were performed on CHO cells membranes expressing hH3R. Retained radioactivity was determined by liquid scintillation count...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422558(CHEMBL434705)
Affinity DataIC50:  79.4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422531(BRIVARACETAM | UCB-34714)
Affinity DataIC50:  100nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422517(CHEMBL149348)
Affinity DataIC50:  100nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422548(CHEMBL150241)
Affinity DataIC50:  125nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422518(CHEMBL358242)
Affinity DataIC50:  125nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422525(CHEMBL348187)
Affinity DataIC50:  158nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422519(CHEMBL358393)
Affinity DataIC50:  199nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422522(CHEMBL347071)
Affinity DataIC50:  251nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422540(CHEMBL152911)
Affinity DataIC50:  251nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422526(CHEMBL359062)
Affinity DataIC50:  398nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422533(CHEMBL150331)
Affinity DataIC50:  398nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422556(CHEMBL358161)
Affinity DataIC50:  501nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422542(Keppra | Keppra Xr | LEVETIRACETAM | Levetiracetam...)
Affinity DataIC50:  794nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422523(CHEMBL358239)
Affinity DataIC50:  794nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422541(CHEMBL149400)
Affinity DataIC50:  1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422555(CHEMBL346223)
Affinity DataIC50:  1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422544(CHEMBL154983)
Affinity DataIC50:  1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422545(CHEMBL345318)
Affinity DataIC50:  1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422549(CHEMBL150791)
Affinity DataIC50:  1.58E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422536(CHEMBL421785)
Affinity DataIC50:  1.58E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422551(CHEMBL358877)
Affinity DataIC50:  1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422534(CHEMBL153282)
Affinity DataIC50:  1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422543(CHEMBL153264)
Affinity DataIC50:  1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 73 total ) | Next | Last >>
Jump to: